149 related articles for article (PubMed ID: 16845408)
1. Could BRAF mutations in melanocytic lesions arise from DNA damage induced by ultraviolet radiation?
Thomas NE; Berwick M; Cordeiro-Stone M
J Invest Dermatol; 2006 Aug; 126(8):1693-6. PubMed ID: 16845408
[TBL] [Abstract][Full Text] [Related]
2. Sunlight ultraviolet irradiation and BRAF V600 mutagenesis in human melanoma.
Besaratinia A; Pfeifer GP
Hum Mutat; 2008 Aug; 29(8):983-91. PubMed ID: 18421705
[TBL] [Abstract][Full Text] [Related]
3. Do Sunscreens Eliminate the Risk of Melanoma?
Pastushenko I; Gilaberte-Calzada Y
Actas Dermosifiliogr; 2015 Dec; 106(10):837-8. PubMed ID: 25772506
[No Abstract] [Full Text] [Related]
4. BRAF analysis on a spectrum of melanocytic neoplasms: an epidemiological study across differing UV regions.
Saroufim M; Habib R; Karram S; Youssef Massad C; Taraif S; Loya A; Houreih MA; Sheikh SS; Amr SS; Satti M; Oberkanins C; Khalifeh I
Am J Dermatopathol; 2014 Jan; 36(1):68-73. PubMed ID: 23782679
[TBL] [Abstract][Full Text] [Related]
5. Predictors of BRAF mutation in melanocytic nevi: analysis across regions with different UV radiation exposure.
Karram S; Novy M; Saroufim M; Loya A; Taraif S; Houreih MA; Rauscher B; Habib RH; Oberkanins C; Khalifeh I
Am J Dermatopathol; 2013 Jun; 35(4):412-8. PubMed ID: 23051629
[TBL] [Abstract][Full Text] [Related]
6. Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma.
Thomas NE; Edmiston SN; Alexander A; Millikan RC; Groben PA; Hao H; Tolbert D; Berwick M; Busam K; Begg CB; Mattingly D; Ollila DW; Tse CK; Hummer A; Lee-Taylor J; Conway K
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):991-7. PubMed ID: 17507627
[TBL] [Abstract][Full Text] [Related]
7. The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sites.
Deichmann M; Krahl D; Thome M; Wüst K; Hassanzadeh J; Helmke B
Int J Oncol; 2006 Jul; 29(1):139-45. PubMed ID: 16773193
[TBL] [Abstract][Full Text] [Related]
8. Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions.
Indsto JO; Kumar S; Wang L; Crotty KA; Arbuckle SM; Mann GJ
J Cutan Pathol; 2007 Jun; 34(6):448-55. PubMed ID: 17518771
[TBL] [Abstract][Full Text] [Related]
9. [Ultraviolet A-induced DNA damage: role in skin cancer].
Beani JC
Bull Acad Natl Med; 2014 Feb; 198(2):273-95. PubMed ID: 26263704
[TBL] [Abstract][Full Text] [Related]
10. RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis.
Dadzie OE; Yang S; Emley A; Keady M; Bhawan J; Mahalingam M
Br J Dermatol; 2009 Feb; 160(2):368-75. PubMed ID: 18945298
[TBL] [Abstract][Full Text] [Related]
11. BRAF V600E Mutations in Nevi and Melanocytic Tumors of Uncertain Malignant Potential.
Seitz-Alghrouz R; Hidalgo JV; Kayser C; Kreutz C; Technau-Hafsi K; Diaz C; von Deimling A; Timmer J; Werner M; Malkovsky M; Fisch P
J Invest Dermatol; 2018 Nov; 138(11):2489-2491. PubMed ID: 29775633
[No Abstract] [Full Text] [Related]
12. Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients.
Schlaak M; Bajah A; Podewski T; Kreuzberg N; von Bartenwerffer W; Wardelmann E; Merkelbach-Bruse S; Büttner R; Mauch C; Kurschat P
Br J Dermatol; 2013 Apr; 168(4):708-16. PubMed ID: 23528057
[TBL] [Abstract][Full Text] [Related]
13. BRAF and NRAS mutations in melanoma and melanocytic nevi.
Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
[TBL] [Abstract][Full Text] [Related]
14. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer.
Rass K; Reichrath J
Adv Exp Med Biol; 2008; 624():162-78. PubMed ID: 18348455
[TBL] [Abstract][Full Text] [Related]
15. BRAF kinase gene V599E mutation in growing melanocytic lesions.
Loewe R; Kittler H; Fischer G; Faé I; Wolff K; Petzelbauer P
J Invest Dermatol; 2004 Oct; 123(4):733-6. PubMed ID: 15373778
[TBL] [Abstract][Full Text] [Related]
16. Activating BRAF mutations in eruptive melanocytic naevi.
Sekulic A; Colgan MB; Davis MD; DiCaudo DJ; Pittelkow MR
Br J Dermatol; 2010 Nov; 163(5):1095-8. PubMed ID: 20716222
[TBL] [Abstract][Full Text] [Related]
17. [MAP-Kinase pathway abnormalities in melanoma: B-RAF is not the sole cause].
Dereure O
Ann Dermatol Venereol; 2012 Oct; 139(10):691-2. PubMed ID: 23122387
[No Abstract] [Full Text] [Related]
18. BRAF mutations in melanocytic tumors (nevi and melanomas) from organ transplant recipients.
Kanitakis J; Baldassini S; Lora V; Euvrard S
Eur J Dermatol; 2010; 20(2):167-71. PubMed ID: 19919912
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the B-RafV600E mutation in cutaneous melanoma patients with occupational sun exposure.
Candido S; Rapisarda V; Marconi A; Malaponte G; Bevelacqua V; Gangemi P; Scalisi A; McCubrey JA; Maestro R; Spandidos DA; Fenga C; Libra M
Oncol Rep; 2014 Mar; 31(3):1079-82. PubMed ID: 24424406
[TBL] [Abstract][Full Text] [Related]
20. BRAF V600 mutation profiling in primary skin nodular melanoma in Indonesia: an analysis using high resolution pyrosequencing.
Rinonce HT; Aji RPM; Hayati N; Pudjohartono MF; Kameswari B; Anwar SL; Irianiwati
BMC Res Notes; 2020 Mar; 13(1):164. PubMed ID: 32188503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
